Budesonide for Crohn's disease

Author： Seow Cynthia H   Benchimol Eric I   Steinhart A Hillary   Griffiths Anne M   Otley Anthony R  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.5, Iss.8, 2009-08, pp. : 971-979

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Budesonide improves QOL in Crohn's disease

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 360, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Budesonide (Entocort ™ EC) Capsules for Crohn’s Disease

By Edsbäcker Staffan  

Clinical Pharmacokinetics, Vol. 43, Iss. 12, 2004-01 ,pp. : 803-821

Adis International

Access to resources Recommend Favorite

Budesonide MRC offers new treatment option for Crohn's disease

By  

Inpharma, Vol. 1, Iss. 1316, 2001-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Budesonide/mesalazine/sulfasalazine: Interstitial pneumonitis, Crohn's disease exacerbation and acute pancreatitis (first report with budesonide): 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1396, 2012-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Budesonide (Entocort EC Capsules): A Review of its Therapeutic Use in the Management of Active Crohn's Disease in Adults

By McKeage K.   Goa K.L.  

Drugs, Vol. 62, Iss. 15, 2002-01 ,pp. : 2263-2282

Adis International

Access to resources Recommend Favorite